Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1974 Jan;53(1):190–197. doi: 10.1172/JCI107537

Effects of Glucagon on Lipolysis and Ketogenesis in Normal and Diabetic Men

John E Liljenquist 1,2,3, James D Bomboy 1,2,3, Stephen B Lewis 1,2,3, Bruce C Sinclair-Smith 1,2,3, Philip W Felts 1,2,3, William W Lacy 1,2,3, Oscar B Crofford 1,2,3, Grant W Liddle 1,2,3
PMCID: PMC301453  PMID: 4808635

Abstract

The effect of glucagon (50 ng/kg/min) on arterial glycerol concentration and net splanchnic production of total ketones and glucose was studied after an overnight fast in four normal and five insulin-dependent diabetic men. Brachial artery and hepatic vein catheters were inserted and splanchnic blood flow determined using indocyanine green. The glucagon infusion resulted in a mean circulating plasma level of 4,420 pg/ml.

In the normal subjects, the glucagon infusion resulted in stimulation of insulin secretion indicated by rising levels of immunoreactive insulin and C-peptide immunoreactivity. Arterial glycerol concentration (an index of lipolysis) declined markedly and net splanchnic total ketone production was virtually abolished. In contrast, the diabetic subjects secreted no insulin (no rise in C-peptide immunoreactivity) in response to glucagon. Arterial glycerol and net splanchnic total ketone production in these subjects rose significantly (P=<0.05) when compared with the results in four diabetics who received a saline infusion after undergoing the same catheterization procedure.

Net splanchnic glucose production rose markedly during glucagon stimulation in the normals and diabetics despite the marked rise in insulin in the normals. Thus, the same level of circulating insulin which markedly suppressed lipolysis and ketogenesis in the normals failed to inhibit the glucagon-mediated increase in net splanchnic glucose production.

It is concluded (a) that glucagon at high concentration is capable of stimulating lipolysis and ketogenesis in insulin-deficient diabetic man; (b) that insulin, mole for mole, has more antilipolytic activity in man than glucagon has lipolytic activity; and (c) that glucagon, on a molar basis, has greater stimulatory activity than insulin has inhibitory activity on hepatic glucose release.

Full text

PDF
190

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARMSTRONG D. T., STEELE R., ALTSZULER N., DUNN A., BISHOP J. S., DE BODO R. C. Regulation of plasma free fatty acid turnover. Am J Physiol. 1961 Jul;201:9–15. doi: 10.1152/ajplegacy.1961.201.1.9. [DOI] [PubMed] [Google Scholar]
  2. AYDIN A., SOKAL J. E. UPTAKE OF PLASMA FREE FATTY ACIDS BY THE ISOLATED RAT LIVER: EFFECT OF GLUCAGON. Am J Physiol. 1963 Oct;205:667–670. doi: 10.1152/ajplegacy.1963.205.4.667. [DOI] [PubMed] [Google Scholar]
  3. Aguilar-Parada E., Eisentraut A. M., Unger R. H. Pancreatic glucagon secretion in normal and diabetic subjects. Am J Med Sci. 1969 Jun;257(6):415–419. doi: 10.1097/00000441-196906000-00008. [DOI] [PubMed] [Google Scholar]
  4. BONDY P. K., CARDILLO L. R. The effect of glucagon on carbohydrate metabolism in normal human beings. J Clin Invest. 1956 May;35(5):494–501. doi: 10.1172/JCI103302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. BORCHGREVINK C. F., HAVEL R. J. TRANSPORT OF GLYCEROL IN HUMAN BLOOD. Proc Soc Exp Biol Med. 1963 Aug-Sep;113:946–949. doi: 10.3181/00379727-113-28539. [DOI] [PubMed] [Google Scholar]
  6. Basso L. V., Havel R. J. Hepatic metabolism of free fatty acids in normal and diabetic dogs. J Clin Invest. 1970 Mar;49(3):537–547. doi: 10.1172/JCI106264. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bieberdorf F. A., Chernick S. S., Scow R. O. Effect of insulin and acute diabetes on plasma FFA and ketone bodies in the fasting rat. J Clin Invest. 1970 Sep;49(9):1685–1693. doi: 10.1172/JCI106386. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Broadus A. E., Kaminsky N. I., Northcutt R. C., Hardman J. G., Sutherland E. W., Liddle G. W. Effects of glucagon on adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate in human plasma and urine. J Clin Invest. 1970 Dec;49(12):2237–2245. doi: 10.1172/JCI106442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Burns T. W., Langley P. E., Robison G. A. Adrenergic receptors and cyclic AMP in the regulation of human adipose tissue lipolysis. Ann N Y Acad Sci. 1971 Dec 30;185:115–128. doi: 10.1111/j.1749-6632.1971.tb45242.x. [DOI] [PubMed] [Google Scholar]
  10. Chernick S. S., Clark C. M., Jr, Gardiner R. J., Scow R. O. Role of lipolytic and glucocorticoid hormones in the development of diabetic ketosis. Diabetes. 1972 Sep;21(9):946–954. doi: 10.2337/diab.21.9.946. [DOI] [PubMed] [Google Scholar]
  11. DREILING D. A., BIERMAN E. L., DEBONS A. F., ELSBACH P., SCHWARTZ I. L. Effect of ACTH, hydrocortisone, and glucagon on plasma nonesterified fatty acid concentration (NEFA) in normal subjects and in patients with liver disease. Metabolism. 1962 Jun;11:572–578. [PubMed] [Google Scholar]
  12. EYMER K. P., SCHWARZ K., WEINGES K. F. [The behavior of esterified and non-esterified fatty acids in the serum under the influence of glucagon and insulin in man]. Klin Wochenschr. 1961 Jun 15;39:631–638. doi: 10.1007/BF01479084. [DOI] [PubMed] [Google Scholar]
  13. Edwards J. C., Taylor K. W. Fatty acids and the release of glucagon from isolated guinea-pig islets of Langerhans incubated in vitro. Biochim Biophys Acta. 1970 Aug 14;215(2):310–315. doi: 10.1016/0304-4165(70)90029-2. [DOI] [PubMed] [Google Scholar]
  14. Glinsmann W. H., Mortimore G. E. Influence of glucagon and 3', 5'-AMP on insulin responsiveness of the perfused rat liver. Am J Physiol. 1968 Sep;215(3):553–559. doi: 10.1152/ajplegacy.1968.215.3.553. [DOI] [PubMed] [Google Scholar]
  15. Goodridge A. G., Ball E. G. Studies on the metabolism of adipose tissue. 18. In vitro effects of insulin, epinephrine and glucagon on lipolysis and glycolysis in pigeon adipose tissue. Comp Biochem Physiol. 1965 Dec;16(4):367–381. doi: 10.1016/0010-406x(65)90303-8. [DOI] [PubMed] [Google Scholar]
  16. Grande F. Lack of insulin effect on free fatty acid mobilization produced by glucagon in birds. Proc Soc Exp Biol Med. 1969 Mar;130(3):711–713. doi: 10.3181/00379727-130-33639. [DOI] [PubMed] [Google Scholar]
  17. HAGEN J. H., MOORHOUSE J. A., STEINBERG J. Effect of insulin on plasma glycerol in man. Metabolism. 1963 Apr;12:346–351. [PubMed] [Google Scholar]
  18. HAGEN J. H. THE EFFECT OF INSULIN ON CONCENTRATION OF PLASMA GLYCEROL. J Lipid Res. 1963 Jan;4:46–51. [PubMed] [Google Scholar]
  19. Heimberg M., Weinstein I., Kohout M. The effects of glucagon, dibutyryl cyclic adenosine 3',5'-monophosphate, and concentration of free fatty acid on hepatic lipid metabolism. J Biol Chem. 1969 Oct 10;244(19):5131–5139. [PubMed] [Google Scholar]
  20. KIBLER R. F., TAYLOR W. J., MYERS J. D. THE EFFECT OF GLUCAGON ON NET SPANCHNIC BALANCES OF GLUCOSE, AMINO ACID NITROGEN, UREA, KETONES, ANS OXYGEN IN MAN. J Clin Invest. 1964 May;43:904–915. doi: 10.1172/JCI104976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. LEEVY C. M., MENDENHALL C. L., LESKO W., HOWARD M. M. Estimation of hepatic blood flow with indocyanine green. J Clin Invest. 1962 May;41:1169–1179. doi: 10.1172/JCI104570. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. LEVARLET M. [Action of adrenaline and glucagon on the blood sugar, lactates and fatty acids]. C R Seances Soc Biol Fil. 1962;156:1940–1942. [PubMed] [Google Scholar]
  23. LIPSETT M. B., ENGEL H. R., BERGENSTAL D. M. Effects of glucagon on plasma unesterified fatty acids and in nitrogen metabolism. J Lab Clin Med. 1960 Sep;56:342–354. [PubMed] [Google Scholar]
  24. Lefebvre P. J., Luyckx A. S. Effect of insulin on glucagon enhanced lipolysis in vitro. Diabetologia. 1969 Jun;5(3):195–197. doi: 10.1007/BF01213680. [DOI] [PubMed] [Google Scholar]
  25. Lefebvre P. Glucagon et taux sanguin des acides gras non estérifiés chez l'homme. Ann Endocrinol (Paris) 1965 Sep-Oct;26(5):602–608. [PubMed] [Google Scholar]
  26. Lefebvre P. The physiological effect of glucagon on fat-mobilisation. Diabetologia. 1966 Sep;2(2):130–132. doi: 10.1007/BF00423023. [DOI] [PubMed] [Google Scholar]
  27. Lewis G. P., Matthews J. The mobilization of free fatty acids from rabbit adipose tissue in situ. Br J Pharmacol. 1968 Nov;34(3):564–578. doi: 10.1111/j.1476-5381.1968.tb08485.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Liljenquist J. E., Bomboy J. D., Lewis S. B., Sinclair-Smith B. C., Felts P. W., Lacy W. W., Crofford O. B., Liddle G. W. Effect of glucagon on net splanchnic cyclic AMP production in normal and diabetic men. J Clin Invest. 1974 Jan;53(1):198–204. doi: 10.1172/JCI107538. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Luyckx A. S., Lefebvre P. J. Arguments for a regulation of pancreatic glucagon secretion by circulating plasma free fatty acids. Proc Soc Exp Biol Med. 1970 Feb;133(2):524–528. doi: 10.3181/00379727-133-34511. [DOI] [PubMed] [Google Scholar]
  30. MAHLER R., STAFFORD W. S., TARRANT M. E., ASHMORE J. THE EFFECT OF INSULIN ON LIPOLYSIS. Diabetes. 1964 May-Jun;13:297–302. [PubMed] [Google Scholar]
  31. Mackrell D. J., Sokal J. E. Antagonism between the effects of insulin and glucagon on the isolated liver. Diabetes. 1969 Nov;18(11):724–732. doi: 10.2337/diab.18.11.724. [DOI] [PubMed] [Google Scholar]
  32. Madison L. L., Seyffert W. A., Jr, Unger R. H., Barker B. Effect on plasma free fatty acids on plasma glucagon and serum insulin concentrations. Metabolism. 1968 Apr;17(4):301–304. doi: 10.1016/0026-0495(68)90097-8. [DOI] [PubMed] [Google Scholar]
  33. McGarry J. D., Foster D. W. Regulation of ketogenesis and clinical aspects of the ketotic state. Metabolism. 1972 May;21(5):471–489. doi: 10.1016/0026-0495(72)90059-5. [DOI] [PubMed] [Google Scholar]
  34. Melani F., Rubenstein A. H., Oyer P. E., Steiner D. F. Identification of proinsulin and C-peptide in human serum by a specific immunoassay. Proc Natl Acad Sci U S A. 1970 Sep;67(1):148–155. doi: 10.1073/pnas.67.1.148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Menahan L. A., Wieland O. Interactions of glucagon and insulin on the metabolism of perfused livers from fasted rats. Eur J Biochem. 1969 May 1;9(1):55–62. doi: 10.1111/j.1432-1033.1969.tb00575.x. [DOI] [PubMed] [Google Scholar]
  36. Mosinger B., Kuhn E., Kujalová V. Action of adipokinetic hormones on human adipose tissue in vitro. J Lab Clin Med. 1965 Sep;66(3):380–389. [PubMed] [Google Scholar]
  37. Pozza G., Pappalettera A., Melogli O., Viberti G., Ghidoni A. Lipolytic effect of intra-arterial injection of glucagon in man. Horm Metab Res. 1971 Jul;3(4):291–292. doi: 10.1055/s-0028-1096783. [DOI] [PubMed] [Google Scholar]
  38. SALTER J. M., EZRIN C., LAIDLAW J. C., GORNALL A. G. Metabolic effects of glucagon in human subjects. Metabolism. 1960 Aug;9:753–768. [PubMed] [Google Scholar]
  39. SARCIONE E. J., BACK N., SOKAL J. E., MEHLMAN B., KNOBLOCK E. Elevation of plasma epinephrine levels produced by glucagon in vivo. Endocrinology. 1963 Apr;72:523–526. doi: 10.1210/endo-72-4-523. [DOI] [PubMed] [Google Scholar]
  40. SCIAN L. F., WESTERMANN C. D., VERDESCA A. S., HILTON J. G. Adrenocortical and medullary effects of glucagon. Am J Physiol. 1960 Nov;199:867–870. doi: 10.1152/ajplegacy.1960.199.5.867. [DOI] [PubMed] [Google Scholar]
  41. Samols E., Marri G., Marks V. Interrelationship of glucagon, insulin and glucose. The insulinogenic effect of glucagon. Diabetes. 1966 Dec;15(12):855–866. doi: 10.2337/diab.15.12.855. [DOI] [PubMed] [Google Scholar]
  42. Sheps S. G., Maher F. T. Histamine and glucagon tests in diagnosis of pheochromocytoma. JAMA. 1968 Sep 23;205(13):895–899. [PubMed] [Google Scholar]
  43. Unger R. H., Aguilar-Parada E., Müller W. A., Eisentraut A. M. Studies of pancreatic alpha cell function in normal and diabetic subjects. J Clin Invest. 1970 Apr;49(4):837–848. doi: 10.1172/JCI106297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Unger R. H. Glucagon and the insulin: glucagon ratio in diabetes and other catabolic illnesses. Diabetes. 1971 Dec;20(12):834–838. doi: 10.2337/diab.20.12.834. [DOI] [PubMed] [Google Scholar]
  45. VAUGHAN M., STEINBERG D. EFFECT OF HORMONES ON LIPOLYSIS AND ESTERIFICATION OF FREE FATTY ACIDS DURING INCUBATION OF ADIPOSE TISSUE IN VITRO. J Lipid Res. 1963 Apr;4:193–199. [PubMed] [Google Scholar]
  46. Warembourg H., Biserte G., Jaillard J., Sezille G. Variations quantitatives et qualitatives des acides gras non estérifiés et des triglycérides circulants induites par le glucagon. Clin Chim Acta. 1970 Apr;28(1):103–110. doi: 10.1016/0009-8981(70)90166-x. [DOI] [PubMed] [Google Scholar]
  47. Whitty A. J., Shima K., Trubow M., Foà P. P. Effect of glucagon and of insulin on serum free fatty acids in normal and depancreatized dogs. Proc Soc Exp Biol Med. 1969 Jan;130(1):55–61. doi: 10.3181/00379727-130-33487. [DOI] [PubMed] [Google Scholar]
  48. Williamson J. R. Effects of fatty acids, glucagon and anti-insulin serum on the control of gluconeogenesis and ketogenesis in rat liver. Adv Enzyme Regul. 1967;5:229–255. doi: 10.1016/0065-2571(67)90019-2. [DOI] [PubMed] [Google Scholar]
  49. Winkler B., Steele R., Altszuler N. Relationship of glycerol uptake to plasma glycerol concentration in the normal dog. Am J Physiol. 1969 Jan;216(1):191–196. doi: 10.1152/ajplegacy.1969.216.1.191. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES